Company
Novelty Nobility
Leadership
SAB
Contact Us
Platform
PREXISE-D
Pipeline
People
Culture
Careers
News
Careers
Publications
Blog
Terms of Use
Private Policy
ddd
Company
Novelty Nobility
Leadership
SAB
Contact Us
Platform
PREXISE-D
Pipeline
People
Culture
Careers
News
Careers
Publications
Blog
Terms of Use
Private Policy
PREXISE-D, Fit-for-Purpose
Antibody Design & Discovery
Learn more
Overcoming Drug Resistance
with Antibody-Drug Conjugate
Learn more
Bringing a Beautiful Moment of
Eye Contact to Everyone
Learn more
NEWS
[팜뉴스] 노벨티노빌리티, 중기부 ‘신약 파이프라인 공동개발 과제’ 선정
[바이오타임즈] 노벨티노빌리티, ‘NN2802’ 중국 임상 1b/2상 승인
[이데일리] 노벨티노빌리티, AGC바이오와 'NN4101' GMP 생산 본격화
[딜사이트] 노벨티노빌리티, 하나증권과 주관사 선정 계약
[이데일리] 박찬희 노벨티노빌리티 CSO "면역염증질환 영역에서 항체 완성도로 승부"...